Biodistribution Profile of Magnetic Nanoparticles in Cirrhosis-Associated Hepatocarcinogenesis in Rats by AC Biosusceptometry

Since magnetic nanoparticles (MNPs) have been used as multifunctional probes to diagnose and treat liver diseases in recent years, this study aimed to assess how the condition of cirrhosis-associated hepatocarcinogenesis alters the biodistribution of hepatic MNPs. Using a real-time image acquisition approach, the distribution profile of MNPs after intravenous administration was monitored using an AC biosusceptometry (ACB) assay. We assessed the biodistribution profile based on the ACB images obtained through selected regions of interest (ROIs) in the heart and liver position according to the anatomical references previously selected. The signals obtained allowed for the quantification of pharmacokinetic parameters, indicating that the uptake of hepatic MNPs is compromised during liver cirrhosis, since scar tissue reduces blood flow through the liver and slows its processing function. Since liver monocytes/macrophages remained constant during the cirrhotic stage, the increased intrahepatic vascular resistance associated with impaired hepatic sinusoidal circulation was considered the potential reason for the change in the distribution of MNPs.

• Publication year

  2022

• Venue

  Pharmaceutics

• Publication date

  2022-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/pharmaceutics14091907PMID 36145654PMCID 9504370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities

  2022cited by this paper
• Long-Term Clearance and Biodistribution of Magnetic Nanoparticles Assessed by AC Biosusceptometry

  2022cited by this paper
• Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis

  2021cited by this paper
• Collagen and elastic fibres in acute and chronic liver injury

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021influential reference
• Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

  2021cited by this paper
• 2D Quantitative Imaging of Magnetic Nanoparticles by an AC Biosusceptometry Based Scanning Approach and Inverse Problem

  2021cited by this paper
• Corona protein impacts on alternating current biosusceptometry signal and circulation times of differently coated MnFe2O4 nanoparticles.

  2021cited by this paper
• Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe

  2021cited by this paper
• The Influence of Omeprazole on the Dissolution Processes of pH-Dependent Magnetic Tablets Assessed by Pharmacomagnetography

  2021cited by this paper
• Critical Role of LSEC in Post-Hepatectomy Liver Regeneration and Failure

  2021cited by this paper
• Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

  2021cited by this paper
• Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment

  2021cited by this paper
• The Space of Disse: The Liver Hub in Health and Disease

  2021influential reference
• Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors

  2021cited by this paper
• Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver

  2021cited by this paper
• In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling

  2021cited by this paper
• Targeting of Hepatic Macrophages by Therapeutic Nanoparticles

  2020cited by this paper
• Molecular imaging of extracellular matrix proteins with targeted probes using magnetic resonance imaging.

  2020cited by this paper
• The Endothelium as a Driver of Liver Fibrosis and Regeneration

  2020cited by this paper
• Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

  2020cited by this paper
• Predictive model for delivery efficiency: erythrocyte membrane-camouflaged magneto-fluorescent nanocarriers study.

  2020cited by this paper
• AC biosusceptometry and magnetic nanoparticles to assess doxorubicin-induced kidney injury in rats.

  2020cited by this paper
• Manganese Ferrite Nanoparticles (MnFe2O4): Size Dependence for Hyperthermia and Negative/Positive Contrast Enhancement in MRI

  2020cited by this paper
• Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis

  2020cited by this paper
• Advantages and Challenges in nanomedicines for chronic liver diseases: a hepatologist's perspectives.

  2020cited by this paper
• Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure

  2020cited by this paper
• Albumin Coating Prevents Cardiac Effect of the Magnetic Nanoparticles

  2019cited by this paper
• Early detection and staging of chronic liver diseases with a protein MRI contrast agent

  2019cited by this paper
• Dynamic cerebral perfusion parameters and magnetic nanoparticle accumulation assessed by AC biosusceptometry

  2019cited by this paper
• Iron oxide nanoparticles as multimodal imaging tools

  2019cited by this paper
• Radiolabeled PET/MRI Nanoparticles for Tumor Imaging

  2019cited by this paper
• Hepatopulmonary syndrome-attributed extreme hypoxemia and polycythemia revealing liver cirrhosis.

  2019cited by this paper
• Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis.

  2019cited by this paper
• Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic inflammation.

  2019cited by this paper
• Reply to: "Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic inflammation".

  2019cited by this paper
• Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.

  2019cited by this paper
• Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease

  2019cited by this paper
• 17-Allylamino-17-demethoxygeldanamycin loaded PCL/PEG nanofibrous scaffold for effective growth inhibition of T47D breast cancer cells

  2019cited by this paper
• Multichannel AC Biosusceptometry System to Map Biodistribution and Assess the Pharmacokinetic Profile of Magnetic Nanoparticles by Imaging

  2019cited by this paper
• Long-term biodistribution and toxicity of curcumin capped iron oxide nanoparticles after single-dose administration in mice.

  2019cited by this paper
• Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels

  2019cited by this paper
• Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings

  2018cited by this paper
• Novel magneto-responsive nanoplatforms based on MnFe2O4 nanoparticles layer-by-layer functionalized with chitosan and sodium alginate for magnetic controlled release of curcumin.

  2018cited by this paper
• Nano based drug delivery systems: recent developments and future prospects

  2018cited by this paper
• Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models

  2018cited by this paper
• Review article: Update on current and emergent data on hepatopulmonary syndrome

  2018cited by this paper
• The Spleen Promotes the Secretion of CCL2 and Supports an M1 Dominant Phenotype in Hepatic Macrophages During Liver Fibrosis

  2018cited by this paper
• The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles

  2018cited by this paper
• Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance

  2018cited by this paper
• Progress in non-invasive detection of liver fibrosis

  2018cited by this paper
• Liver Fibrosis Quantification by Magnetic Resonance Imaging

  2017cited by this paper
• Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometry

  2017cited by this paper
• Ultrasound Evaluation of Liver Fibrosis

  2017cited by this paper
• Nanoparticles for the treatment of liver fibrosis

  2017cited by this paper
• Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent.

  2017cited by this paper
• Effect of removing Kupffer cells on nanoparticle tumor delivery

  2017cited by this paper
• CD68/macrosialin: not just a histochemical marker

  2017cited by this paper
• Glioblastoma Targeted Gene Therapy Based on pEGFP/p53-Loaded Superparamagnetic Iron Oxide Nanoparticles.

  2017cited by this paper
• The spleen in liver cirrhosis: revisiting an old enemy with novel targets

  2017cited by this paper
• The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome

  2017cited by this paper
• Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis.

  2017cited by this paper
• A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug delivery.

  2017cited by this paper
• Pathological process of liver sinusoidal endothelial cells in liver diseases

  2017cited by this paper
• Real-time liver uptake and biodistribution of magnetic nanoparticles determined by AC biosusceptometry.

  2017cited by this paper
• Liver fibrosis: Review of current imaging and MRI quantification techniques

  2017cited by this paper
• An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features.

  2017cited by this paper
• Analysis of nanoparticle delivery to tumours

  2016cited by this paper
• Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.

  2016cited by this paper
• Pentenoic Acid-Stabilized Magnetic Nanoparticles for Nanomedicine Applications

  2016cited by this paper
• Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment

  2016cited by this paper
• Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice.

  2016cited by this paper
• Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice

  2016cited by this paper
• Magnetic Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.

  2016cited by this paper
• Magnetic Particle Imaging tracks the long-term fate of in vivo neural cell implants with high image contrast

  2015cited by this paper
• Iron Oxide Nanoparticles Induce Dopaminergic Damage: In vitro Pathways and In Vivo Imaging Reveals Mechanism of Neuronal Damage

  2015cited by this paper
• State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives

  2015cited by this paper
• Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis

  2015cited by this paper
• Dual-pH Sensitive Charge-Reversal Polypeptide Micelles for Tumor-Triggered Targeting Uptake and Nuclear Drug Delivery.

  2015cited by this paper
• Non-invasive diagnosis of liver fibrosis and cirrhosis.

  2015cited by this paper
• Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation.

  2015cited by this paper
• Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

  2014cited by this paper
• Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.

  2014cited by this paper
• Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings

  2014cited by this paper
• Effect of magnetic dipolar interactions on nanoparticle heating efficiency: Implications for cancer hyperthermia

  2013cited by this paper
• Physiological and Biochemical Basis of Clinical Liver Function Tests: A Review

  2013cited by this paper
• Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration

  2013cited by this paper
• Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort

  2012cited by this paper
• Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells

  2012cited by this paper
• 99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes

  2012cited by this paper
• Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.

  2011cited by this paper
• Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells.

  2011cited by this paper
• In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liver.

  2011cited by this paper
• Nanotechnology for therapy and imaging of liver diseases.

  2011cited by this paper
• Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.

  2011cited by this paper
• Long term in vivo biotransformation of iron oxide nanoparticles.

  2011cited by this paper
• The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.

  2011cited by this paper
• Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.

  2010cited by this paper
• MR imaging of liver fibrosis: current state of the art.

  2009cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper

• Unshielded Portable Gradiometer Setup for the Characterization of Magnetic Nanoparticles in Flow Condition

  2026cites this paper
• Design and optimization of PLGA-based gemcitabine nanocapsule for enhanced pancreatic cancer efficacy

  2025cites this paper
• Embracing cancer immunotherapy with manganese particles

  2025cites this paper
• Investigating the impact of Multiwalled Carbon Nanotubes exposure on enzymatic activities and histopathological variations in Swiss albino mice

  2025cites this paper
• A Review on Ultrasound-based Methods to Image the Distribution of Magnetic Nanoparticles in Biomedical Applications.

  2024cites this paper
• ACCESSING THE PHARMACOKINETICS OF MAGNETIC NANOPARTICLES IN CIRRHOSIS-ASSOCIATED HEPATOCARCINOGENESIS BY ORDINARY DIFFERENTIAL EQUATION MODELING AND AC BIOSUSCEPTOMETRY

  2024cites this paper
• Understanding nanoparticle-liver interactions in nanomedicine

  2024cites this paper
• On the Road to Precision Medicine: Magnetic Systems for Tissue Regeneration, Drug Delivery, Imaging, and Theranostics

  2023cites this paper
• Evaluation of a Balloon Implant for Simultaneous Magnetic Nanoparticle Hyperthermia and High-Dose-Rate Brachytherapy of Brain Tumor Resection Cavities

  2023cites this paper
• Nanodrug delivery: Strategies to circumvent nanoparticle trafficking by Kupffer cells in the liver

  2023cites this paper